Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-08-31
1992-03-24
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3152
Patent
active
050989065
ABSTRACT:
Novel purine derivatives are described as agents for treating autoimmune diseases as well as a method of manufacture and pharmaceutical compositions as well as novel intermediates in the manufacture thereof.
REFERENCES:
patent: 597765 (1984-04-01), Martel
patent: 4199574 (1980-04-01), Schaeffer
EPO Search Report with attachments.
EPO Search Report 87 108733.4.
EPO Search Report 87 108734.2.
Merck Index, 10th edition, p. 146.
"Inhibition of Human Purine Nucleoside . . . ", Biochemcial Pharmacology, vol. 36, No. 8, pp. 1237-1244, 1987, Stein.
Chemical Abstracts, vol. 66; 85984j, p. 8064.
Abstract from Pharmaceuticals, p. 4, week 8545-Derwent 85-263355/43=DE 3521-303-A.
Schwender Charles
Sircar Jagadish C.
Suto Mark J.
Fay Zohreh A.
Thierstein Joan
Waddell Frederick E.
Warner-Lambert & Company
LandOfFree
Purine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010405